Roxadustat
- Introduction
- Newest Products
Introduction
Roxadustat
Roxadustat is an orally administered, small molecule hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor for the treatment of anaemia in patients with dialysis-dependent chronic kidney disease (CKD), non-dialysis-dependent CKD and in patients with myelodysplastic syndromes.
Newest Products
| Image | Part # | Description | manufacturer | Stock | RFQ | |
|---|---|---|---|---|---|---|
|
|
4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic Acid Methyl Ester 1421312-34-6 |
CAS: 1421312-34-6; Roxadustat manufacturer; Roxadustat intermediate
|
|
In Stock
|
|
|
|
|
4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester (1809286-36-9) |
CAS: 1809286-36-9; Roxadustat manufacturer; Roxadustat intermediate
|
|
In Stock
|
|
|
|
|
4-hydroxy-7-phenoxyisoquinoline-3-carboxylic acid methyl ester (1455091-10-7) |
CAS: 1455091-10-7; Roxadustat manufacturer; Roxadustat intermediate; Roxadustat impurity 4
|
|
In Stock
|
|
|
|
|
Roxadustat (808118-40-3) |
CAS: 808118-40-3; Roxadustat manufacturer; Roxadustat API; Chronic Kidney Disease
|
|
In Stock
|
|
